Breaking News, Collaborations & Alliances

Phlow Expands Continuous Manufacturing R&D Services

Enters agreements with Virginia Commonwealth University’s Medicines for All Institute and AMPAC Fine Chemicals.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Phlow Corp., a U.S.-based essential medicines public benefit company, has entered alliances with both Virginia Commonwealth University’s (VCU) Medicines for All Institute and AMPAC Fine Chemicals to provide contract continuous manufacturing research and development (R&D) services for small molecule pharmaceutical products. In addition to its internal capabilities, Phlow’s network of established partners will provide high quality, U.S.-based advanced manufacturing solutions for small molecule...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters